drug
apraglutide
Phase 3updated 6mo agoby $IRWD IRONWOOD PHARMACEUTICALS INC
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying apraglutide
- phase3A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)
- phase2Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)
- phase1A Phase 1 Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects With Normal and Impaired Hepatic Function
- phase3Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.
- phase2Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC)
- phase3Trial to Evaluate Efficacy and Safety of Apraglutide in SBS-IF
- phase1Study of Pharmacokinetics and Safety of Apraglutide in Participants With Normal and Impaired Kidney Function.
- phase1Relative Bioavailability of a New Presentation of Apraglutide Versus the Reference Formulation
News(1)
- Chutes & Ladders—Troubled CSL enlists GSK vet Deborah Waterhouse to leadCSL has tapped a new leader to steer it through a make-or-break period. Ironwood's CEO since 2021 is hanging up his hat. CytoDyn's new helmsman is highlighting the company's "transformational perio…fiercebiotech · 28d ago
Data sources
last refreshed 7h ago
Found something off?
comments(0)
5-min edit window · permanent after that